Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9570-9577
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9570
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9570
Table 2 Clinical data n (%)
| Mean number of procedures (range) | 2.7 ± 0.1 SD |
| Mean total therapeutic time (h) per case (range) | 2.4 ± 0.1 SD |
| Rate of complete tumor ablation | 24/30 (80) |
| Rate of anesthesia/sedation administered | 0/30 (0) |
| Rate of pain killer administered | 1/30 (3.3) |
- Citation: Sofuni A, Moriyasu F, Sano T, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Ikeuchi N, Tanaka R, Umeda J, Tonozuka R, Honjo M, Mukai S, Fujita M, Itoi T. Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer. World J Gastroenterol 2014; 20(28): 9570-9577
- URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9570.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9570